Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 10;17(1):187.
doi: 10.1186/s12886-017-0587-z.

Low recurrence rate of anchored conjunctival rotation flap technique in pterygium surgery

Affiliations

Low recurrence rate of anchored conjunctival rotation flap technique in pterygium surgery

Dong Ju Kim et al. BMC Ophthalmol. .

Abstract

Background: To report the recurrence rate for an anchored conjunctival rotation flap technique in primary pterygium surgery.

Methods: Primary pterygium surgeries performed using anchored conjunctival rotation flap techniques (110 eyes in 110 patients) with a minimum follow-up of 12 months were reviewed. In this technique, a conjunctival flap is rotated to cover the bare sclera and suture-fixated with either 8-0 polyglactin (41 eyes) or 10-0 nylon (69 eyes). The recurrence rate was determined, and the two suture materials utilized were compared.

Results: The recurrence rate was 2.71% (3 cases in 110 eyes) when an anchored conjunctival rotation flap technique was used and patients were monitored for 26.40 ± 17.09 months. Interestingly, the recurrences were only observed in polyglactin-sutured eyes. No recurrence was detected in nylon-sutured eyes. No other complications were observed in either group.

Conclusions: The anchored conjunctival rotation flap technique for pterygium surgery has a relatively low recurrence rate. Nylon suture-fixation of the flap was found to be superior to polyglactin suture-fixation in preventing recurrence.

Keywords: Anchored; Flap; Nylon; Polyglactin; Pterygium; Recurrence.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This study followed the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of Dongguk University, Ilsan Hospital, Goyang, South Korea (IRB no. 2016–137).

Consent for publication

Written informed consents were obtained from patients to publish materials and figures included in this study.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
a & b: Primary pterygium before (a) and 48 months after (b) the anchored conjunctival rotation flap surgery in 54 year old male patient. Status of preoperative pterygium was graded as S3V3C3K3. The healing was accomplished with almost normal conjunctival appearance (grade 1). c & d: Representative pictures of the postoperative appearance of anchored conjunctival rotation flaps were shown. The conjunctival flaps were well maintained with normal vascularity. Arrows indicate the margin of the conjunctival flap. c: Forty eight months after the surgery in a 53 year old male patient (postoperative status grade 1). d: Twelve eight months after the surgery in a 68 year old male patient (postoperative status grade 1)
Fig. 2
Fig. 2
a: Thick and fleshy primary pterygium (S4V3C4K3) is observed with destruction of plica semilunaris and caruncle distortion in 61 year old female. b and c: Twelve month after surgery, focal presence of fine episcleral vessels (red arrow) reaching to the limbus is observed with thickened conjunctival wound edge (white arrow) (postoperative status, grade 2). d: Thick and atrophic primary pterygium (S3V2C3K4) is observed with dragging of plica semilunaris in 54 year old male. e: One month after surgery, significant contraction of conjunctival flap (red arrows) was observed with advancement of fibrovascular tissue (white arrows) from nasal conjunctiva. Monthly subconjunctival injection of bevacizumab (2.5 mg in 0.1 ml) and dexamethasone (0.5 mg in 0.1 ml) into the fibrovascular tissue was carried three times. f: Twelve month after surgery, fibrovascular tissue growth (white arrows) was halted with clear conjunctiva (red arrows) (postoperative status, grade 1)

Similar articles

Cited by

References

    1. Clearfield E, Muthappan V, Wang X, Kuo IC. Conjunctival autograft for pterygium. Cochrane Database Syst Rev. 2016;2:CD011349. - PMC - PubMed
    1. Al Fayez MF. Limbal-conjunctival vs conjunctival autograft transplant for recurrent pterygia: a prospective randomized controlled trial. JAMA Ophthalmol. 2013;131(1):11–6. - PubMed
    1. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 1985;92(11):1461–1470. doi: 10.1016/S0161-6420(85)33831-9. - DOI - PubMed
    1. Hirst LW. Recurrence and complications after 1000 surgeries using pterygium extended removal followed by extended conjunctival transplant. Ophthalmology. 2012;119(11):2205–10. - PubMed
    1. Kheirkhah A, Nazari R, Nikdel M, Ghassemi H, Hashemi H, Behrouz MJ. Postoperative conjunctival inflammation after pterygium surgery with amniotic membrane transplantation versus conjunctival autograft. Am J Ophthalmol. 2011;152(5):733–8. - PubMed

LinkOut - more resources